NSC-Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease (NCT06995573) | NSC-Therapeutics | 2025-08-25 |
Track NSC-Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.